Vaccination against and treatment of tuberculosis, the leishmaniases and AIDS: Perspectives from basic immunology and immunity to chronic intracellular infections

Cellular and Molecular Life Sciences

Volumn 58, Issue 12-13, 2001, Pages 1879-1896

  Bretscher, P A ^a   Ismail, N ^b   Menon, J N ^a   Power, C A ^c   Uzonna, J ^d   Wei, G ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b University of Texas Medical Branch School of Medicine   (United States)

^c CENTENARY INSTITUTE   (Australia)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

AIDS; Immune class regulation; Leishmaniases; Th1 Th2 cells; Treatment; Tuberculosis; Vaccination

Indexed keywords

ANTIBODY; ANTIGEN; ANTIMONY DERIVATIVE; BCG VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 12; INTERLEUKIN 4 ANTIBODY; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY PRODUCTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; LEISHMANIASIS; REVIEW; TH2 CELL; TUBERCULOSIS; VACCINATION;

HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM BOVIS BCG; VARIOLA VIRUS;

EID: 0035197967     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000824     Document Type: Review

References (96)

1. Global epidemiology of tuberculosis: Morbidity and mortality of a worldwide epidemic
2. Regulation of immunity to parasites by T cells and T cell-derived cytokines
3. Cellular immunity
4. Remedy for tuberculosis
5. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy contacts
6. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine responses of blood lymphocytes to mycobacterial antigens
7. The pathogenesis of tuberculosis
8. Immune responses in HIV-exposed seronegatives: Have they repelled the virus?
9. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection
10. Immunity in kala-azar
11. The regulation of immunity to Leishmania major
12. Leishmania donovani-reactive Th1 and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis
13. Occurrence of delayed-hypersensitivity during the development of Arthus-type hypersensitivity
14. Selective and specific inhibition of 24 hour skin reactions in the guinea pig. I. Immune deviation: Description of the phenomenon and the effect of splenectomy
15. The relationship between cell-mediated and humoral immunity
16. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major
17. Hypothesis: On the control between cell-mediated, IgM and IgG immunity
18. Regulation of the immune response. II. Repressor T cells in cyclophosphamide-induced tolerant mice
19. Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity
20. Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera
21. Two types of murine helper T cell clone: Definition according to profiles of lymphokine activities and secreted proteins
22. Specific suppression of immune responses by T cells
23. Significance and mechanisms of cellular regulation of the immune response
24. Quantitative considerations in the design of vaccination strategies against pathogens uniquely susceptible to cell-mediated attack
25. The murine antitumor immune response and its therapeutic manipulation
26. Tumor-specific transplantation antigens
27. Macrophage-digested antigen as inducer of delayed-type hypersensitivity
28. The lesions in cell-membranes caused by complement
29. An hypothesis to explain why cell-mediated immunity alone can contain infections by certain intracellular parasites and how immune class regulation of the response against such parasites can be subverted
30. Influence of antigenicity of target cells on the antibody-mediated cytotoxicity of nonsensitized lymphocytes
31. Effect of antigen density of complement-mediated lysis, T-cell-mediated killing and antigenic modulation
32. An immunological relationship between group A Streptococcus and mammalian muscle
33. Immunological defenses against cancer
34. + T cells induce wasting disease with multiple organ pathology: Prevention by the OX-22 low subset
35. T cells cooperating in the induction of delayed-type hypersensitivity act via the linked recognition of antigenic determinants
36. Functional cooperation between T helper cell determinants
37. More antigen-dependent CD4(+) T cell/CD4(+) T cell interactions are required for the primary generation of Th2 than of Th1 cells
38. Cytokine secretion patterns and cross-regulation of T cell subsets
39. Ignition of the type 1 response to intracellular infection by dendritic cell-derived interleukin-12
40. Influence of dose and route of antigen injection on the immunological induction of T cells
41. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques
42. Low level infection with Trichuris muris significantly affects the polarisation of the CD4 response
43. Induction of protective CTL responses in newborn mice by a murine retrovirus
44. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous or intradermal route
45. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection
46. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG
47. The Th1/Th2 nature of concurrent immune responses to unrelated antigens can be independent
48. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance
49. Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen
50. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth
51. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy
52. BCG vaccination against tuberculosis and leprosy
53. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: Evidence for a T-cell dependent, interferon γ-independent mechanism
54. Recombinant IL12 cures mice infection with Leishmania major
55. Cellular and humoral immunity in genetically susceptible mice after in vivo depletion of L3T4+ T cells
56. Therapeutic effect of anti-L3T4 monoclonal GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice
57. Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major
58. Recombinant IL12 cures mice infected with Leishmania major
59. Distinct immunity in visceral leishmaniasis patients from that in subclinically infected and drug-cured people: Implications for the mechanism underlying drug-cure
60. Characterisation of the immunological memory state generated in susceptible mice to Leishmania major following exposure to low doses of L. major and resulting in resistance to immunity to pathogenic challenge
61. Research on BCG vaccination
62. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route, strain of host or of parasite
63. A case for a neonatal, low dose BCG vaccination trial
64. Development of a natural model of cutaneous leishmaniasis: Powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis
65. Cellular immune responses in rhesus macaques infected rectally with low dose simian immunodeficiency virus
66. Selecting and maintaining a diverse T cell repertoire
67. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis
68. Comparison of the immune profile of nonhealing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection
69. Histological classification and the immunological spectrum of leprosy
70. Koch's treatment at the Royal National Hospital for Consumption Ventor
71. The effect of Koch's remedy on the internal organs of tuberculous patients
72. Resistance to HIV-1 infection among prostitutes
73. HIV-1-specific cellular immune responses among HIV-1-resistant sex workers
74. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood
75. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1
76. Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens
77. Cytotoxic T cell responses in the peripheral blood of children born to HIV-1-infected mothers
78. HIV-specific CTL activity in an HIV-exposed but uninfected infant
79. Occurence of HIV-1-specific cytolytic T cell activity in apparently uninfected children born to HIV-1 infected mothers
80. + cell-produced anti-viral factors in protective immunity in HIV-2-exposed but seronegative macaques resistant to intrarectal SIVsm challenge
81. The critical need for CD4 help
82. Association between virus-specific cytotoxic T lymphocyte and helper responses in human immunodeficiency virus type-1 infection
83. + T-cell responses to CMV in HIV-1-infected subjects
84. High viral burden in the presence of major HIV-specific CD8+ T cell expansions: Evidence for impaired CTL effector function
85. 89.6P)
86. Induction of long-term protective effects against heterologous challenge in SIVhu-infected macaques
87. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection
88. T cells expressing delayed-type hypersensitivity can be derived from a humorally immune lymphocyte population
89. Antigenic properties of methycholanthrene-induced tumors in mice of the strain of origin
90. Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia
91. Lung carcinoma: Analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry
92. Impaired production of Th1 cytokines and increased frequency of Th2 subsets in PBMC from advanced cancer patients
93. T-helper 2 dominant antilymphoma immune response is associated with fatal outcome
94. T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas
95. Tumor antigens recognized by T lymphocytes